Comparison of glibenclamide and insulin on neonatal outcomes in pregnant women with gestational diabetes

International Journal of Preventive Medicine

Volumn 2016-June, Issue , 2016, Pages

  Behrashi, Mitra ^a   Samimi, Mansooreh ^a   Ghasemi, Tayyebeh ^a   Saberi, Farzaneh ^a   Atoof, Fatemeh ^a  

^a KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Gestational diabetes; Glibenclamide; Insulin

Indexed keywords

BILIRUBIN; CALCIUM; GLIBENCLAMIDE; HEMOGLOBIN A1C; INSULIN;

ADULT; AGE DISTRIBUTION; APGAR SCORE; ARTICLE; BILIRUBIN BLOOD LEVEL; BODY MASS; CALCIUM BLOOD LEVEL; CLINICAL EFFECTIVENESS; CONGENITAL MALFORMATION; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; GLUCOSE TOLERANCE TEST; HIGH RISK PATIENT; HUMAN; HYPERBILIRUBINEMIA; HYPOGLYCEMIA; MACROSOMIA; MAJOR CLINICAL STUDY; MALE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NEWBORN INTENSIVE CARE; PATIENT EDUCATION; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR;

EID: 84976337112     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: 10.4103/2008-7802.184502     Document Type: Article

References (38)

1. Alwan N, Tuffnell DJ, West J. Treatments for gestational diabetes (Review). Cochrane Libr 2009;3: 1-57.
2. McCance DR. Diabetes in pregnancy. Best Pract Res Clin Obstet Gynaecol 2015;29: 685-99.
3. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26 Suppl 1: S5-20.
4. American Diabetes Association. Gestational diabetes mellitus (Position Statement). Diabetes Care 2004;27 Suppl 1: S88-90.
5. Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 1998;21 Suppl 2: B161-7.
6. Kimber-Trojnar Z, Marciniak B, Leszczynska-Gorzelak B, Trojnar M, Oleszczuk J. Glyburide for the treatment of gestational diabetes mellitus. Pharmacol Rep 2008;60: 308-18.
7. Reece EA, Homko CJ. Diabetes mellitus in pregnancy. What are the best treatment options? Drug Saf 1998;18: 209-20.
8. Balsells M, Corcoy R, Mauricio D, Morales J, Garcia-Patterson A, Carreras G, et al. Insulin antibody response to a short course of human insulin therapy in women with gestational diabetes. Diabetes Care 1997;20: 1172-5.
9. Weiss PA, Kainer F, Pürstner P, Zehetleitner G, Hüttner U, Haas J. Anti-insulin antibodies and birth weight in pregnancies complicated by diabetes. Early Hum Dev 1998;53: 145-54.
10. Canningham FG, Leveno KJ, Bloom SL, Catherine YS, Dashe JS, Hoffman BL, et al. Williams Obstetrics. 24th ed. New York: McGraw-Hill; 2014.
11. Maymone AC, Baillargeon JP, Ménard J, Ardilouze JL. Oral hypoglycemic agents for gestational diabetes mellitus? Expert Opin Drug Saf 2011;10: 227-38.
12. Mesdaghinia E, Samimi M, Homaei Z, Saberi F, Moosavi SG, Yaribakht M. Comparison of newborn outcomes in women with gestational diabetes mellitus treated with metformin or insulin: A randomised blinded trial. Int J Prev Med 2013;4: 327-33.
13. Dhulkotia JS, Ola B, Fraser R, Farrell T. Oral hypoglycemic agents vs insulin in management of gestational diabetes: A systematic review and metaanalysis. Am J Obstet Gynecol 2010;203: 457.e1-9.
14. Ramos GA, Jacobson GF, Kirby RS, Ching JY, Field DR. Comparison of glyburide and insulin for the management of gestational diabetics with markedly elevated oral glucose challenge test and fasting hyperglycemia. J Perinatol 2007;27: 262-7.
15. Balsells M, Garcia-Patterson A, Solà I, Roqué M, Gich I, Corcoy R. Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: A systematic review and meta-analysis. BMJ 2015;350: h102.
16. Szkróbka W, Herman ZS, Okopieñ B. Extralipid effects of hypolipidemic drugs-Why do clinical trials weakly support experimental data? Pharmacol Rep 2007;59 Suppl 1: 129-33.
17. Ilkhanipoor H, Karamizadeh Z. Changing the treatment of permanent neonatal diabetes mellitus from insulin to glibenclamide in a 4-month-old infant with KCNJ11 activating mutation. Int J Prev Med 2013;4: 1078-81.
18. Gilson G, Murphy N. Comparison of oral glyburide with insulin for the management of gestational diabetes mellitus in Alaska Native women (abstract). Am J Obstet Gynecol 2002;187: S152.
19. Conway DL, Gonzales O, Skiver D. Use of glyburide for the treatment of gestational diabetes: The San Antonio experience. J Matern Fetal Neonatal Med 2004;15: 51-5.
20. Gedeon C, Koren G. Designing pregnancy centered medications: Drugs which do not cross the human placenta. Placenta 2006;27: 861-8.
21. Szewczyk A, Mikolajek B, Pikula S, Nalecz MJ. Potassium channel openers induce mitochondrial matrix volume changes via activation of ATP-sensitive K+channel. Pol J Pharmacol 1993;45: 437-43.
22. Groop LC, Barzilai N, Ratheiser K, Luzi L, Wåhlin-Boll E, Melander A, et al. Dose-dependent effects of glyburide on insulin secretion and glucose uptake in humans. Diabetes Care 1991;14: 724-7.
23. Groop L, Luzi L, Melander A, Groop PH, Ratheiser K, Simonson DC, et al. Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects. Diabetes 1987;36: 1320-8.
24. Moretti ME, Rezvani M, Koren G. Safety of glyburide for gestational diabetes: A meta-analysis of pregnancy outcomes. Ann Pharmacother 2008;42: 483-90.
25. Silva JC, Bertini AM, Taborda W, Becker F, Bebber FR, Aquim GM, et al. Glibenclamide in the treatment for gestational diabetes mellitus in a compared study to insulin. Arq Bras Endocrinol Metabol 2007;51: 541-6.
26. Zeng YC, Li MJ, Chen Y, Jiang L, Wang SM, Mo XL, et al. The use of glyburide in the management of gestational diabetes mellitus: A meta-analysis. Adv Med Sci 2014;59: 95-101.
27. Cheng YW, Chung JH, Block-Kurbisch I, Inturrisi M, Caughey AB. Treatment of gestational diabetes mellitus: Glyburide compared to subcutaneous insulin therapy and associated perinatal outcomes. J Matern Fetal Neonatal Med 2012;25: 379-84.
28. Langer O, Yogev Y, Most O, Xenakis EM. Gestational diabetes: The consequences of not treating. Am J Obstet Gynecol 2005;192: 989-97.
29. Zangeneh M, Veisi F, Ebrahimi B, Rezavand N. Comparison of therapeutic effects of insulin and glibenclamide in gestational diabetes. IJOGI 2014;17: 1-7.
30. Cunningham FG, Leveno KJ, Bloom SL, Spong CY, Dashe JS, Hoffman BL, et al. Williams Obstetrics. 24th ed. New York: McGraw Hill; 2014.
31. Jacobson GF, Ramos GA, Ching JY, Kirby RS, Ferrara A, Field DR. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. Am J Obstet Gynecol 2005;193: 118-24.
32. Tempe A, Mayanglambam RD. Glyburide as treatment option for gestational diabetes mellitus. J Obstet Gynaecol Res 2013;39: 1147-52.
33. Song Y, Zhang S, Song W. Correlation between macrosomia body indices and maternal fasting blood glucose. J Obstet Gynaecol 2014;34: 289-92.
34. Mukhopadhyay P, Bag TS, Kyal A, Saha DP, Khalid N. Oral hypoglycemic glibenclamide: Can it be a substitute to insulin in the management of gestational diabetes mellitus? A comparative study. J South Asian Fed Obstet Gynaecol 2012;4: 28-31.
35. Homko CJ, Sivan E, Reece AE. Is there a role for oral antihyperglycemics in gestational diabetes and type 2 diabetes during pregnancy? Treat Endocrinol 2004;3: 133-9.
36. Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000;343: 1134-8.
37. Elliott BD, Schenker S, Langer O, Johnson R, Prihoda T. Comparative placental transport of oral hypoglycemic agents in humans: A model of human placental drug transfer. Am J Obstet Gynecol 1994;171: 653-60.
38. Kraemer J, Klein J, Lubetsky A, Koren G. Perfusion studies of glyburide transfer across the human placenta: Implications for fetal safety. Am J Obstet Gynecol 2006;195: 270-4.